3

PRIMARY DOCUMENT

Company: Kiniksa Pharmaceuticals International, plc
Filed: May 23, 2018
Period of Report: May 23, 2018
Accession Number: 0001638599-18-000573

View Document ↗ View on SEC.gov ↗